Anus Neoplasms: all 269 studies
Page 2 of 3. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.
- Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsCompletedNCT02135419Phase 3Results posted
- Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIVCompletedNCT01946139Not applicableResults posted
- [F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersCompletedNCT01717391Phase 2Results posted
- A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal CancerTerminatedNCT01671488Phase 1/2Results posted
- Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)CompletedNCT01651949Phase 3Results posted
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated CancersCompletedNCT01585428Phase 2Results posted
- Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the AnusCompletedNCT01581840Phase 1/2Results posted
- Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal CancerTerminatedNCT01324141Phase 1Results posted
- Cancer in Patients With Gabapentin (GPRD)CompletedNCT01236053Results posted
- Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With MalesCompletedNCT01209325Phase 2Results posted
- Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal NeoplasiaCompletedNCT01164722Phase 3Results posted
- Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
- Men's Beliefs About Associations Between HPV, Cancers, and HPV VaccinationCompletedNCT00799474Results posted
- Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical CreamCompletedNCT00622440Phase 2Results posted
- Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the AnusCompletedNCT00550589Phase 2Results posted
- Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerCompletedNCT00423293Phase 2Results posted
- Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerCompletedNCT00324415Phase 2Results posted
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerCompletedNCT00316888Phase 2Results posted
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedNCT00093379Phase 2Results posted
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIVWithdrawnNCT07090174Phase 2
- Tolerance to Immunomodulatory Nutritional Therapy in Oncology Patients Undergoing Chemotherapy and RadiotherapyCompletedNCT07021378Not applicable
- Assessing the Utility of Plasma ctHPVDNA for Anal Cancer ScreeningCompletedNCT06971276
- A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesActive, not recruitingNCT06866574Phase 3
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
- Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
- A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese MalesActive, not recruitingNCT06465914Phase 3
- REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity MitigationActive, not recruitingNCT05902533Phase 2/3
- Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsCompletedNCT05858736Phase 1
- Anal Intraepithelial Neoplasia and Anal Squamous Cell CarcinomaStatus unknownNCT05835960
- Anal Cancer Risk In WomenStatus unknownNCT05835947
- ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIESActive, not recruitingNCT05628194
- Human Papillomavirus in Young People Epidemiological Research 4Status unknownNCT05587738
- Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidCompletedNCT05578820Phase 1
- PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in DenmarkActive, not recruitingNCT05570279
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-oldCompletedNCT05518201Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-IIActive, not recruitingNCT05385250Not applicable
- Role of Antisecretory Factor in Curative Radiochemotherapy for Anal CarcinomaStatus unknownNCT05351931Not applicable
- A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV InfectionCompletedNCT05328765
- Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the AnusCompletedNCT05201105
- 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell CancerCompletedNCT05130073
- CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck CancersStatus unknownNCT05122221Phase 1
- Assessment of Patients' Quality of Sexual Life After Anal Cancer TreatmentCompletedNCT05109468
- PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsCompletedNCT05060471Phase 2
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerActive, not recruitingNCT04929028Phase 2
- Education, Immigration and HPV Vaccination: an Informational Randomized TrialStatus unknownNCT04905030Not applicable
- Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.Active, not recruitingNCT04719988Phase 2
- Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyActive, not recruitingNCT04713618
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon CancersCompletedNCT04708470Phase 1/2
- RTX-321 Monotherapy in Patients With HPV 16+ TumorsTerminatedNCT04672980Phase 1
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of PembrolizumabWithdrawnNCT04536922Phase 2
- Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialCompletedNCT04534075Phase 3
- Anal Injury Screening for High Risk HPVStatus unknownNCT04512508Not applicable
- EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer PatientsActive, not recruitingNCT04444921Phase 3
- Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsCompletedNCT04357873Phase 2
- Phase 1 Study of Oral TP-1454CompletedNCT04328740Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsTerminatedNCT04272034Phase 1
- Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study GroupActive, not recruitingNCT04230759Phase 2
- Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyActive, not recruitingNCT04166318Phase 2
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsCompletedNCT04157985Phase 3
- A Multilevel Intervention to Improve Timely Cancer Detection and Treatment InitiationActive, not recruitingNCT04141449Phase 2
- Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)Status unknownNCT04109573Not applicable
- High-Resolution Anoscopy Perceived Discomfort StudyCompletedNCT04083053Not applicable
- Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of AnusActive, not recruitingNCT04046133Phase 1
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal FistulaCompletedNCT03983174Not applicable
- Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)Status unknownNCT03944252Phase 2
- Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal CarcinomaWithdrawnNCT03942900
- Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)Status unknownNCT03870607Phase 2
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionTerminatedNCT03677960Phase 1
- A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaCompletedNCT03519295Phase 2
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CTCompletedNCT03506529
- Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?CompletedNCT03469596
- Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose RatesCompletedNCT03465501
- Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal CancerActive, not recruitingNCT03386500Phase 1/2
- Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal CancerStatus unknownNCT03381352Phase 2
- E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSMStatus unknownNCT03357991
- Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionCompletedNCT03346915Not applicable
- A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal WandStatus unknownNCT03302858Phase 2
- Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)Status unknownNCT03241680Not applicable
- Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerActive, not recruitingNCT03233711Phase 3
- PEN-866 in Patients With Advanced Solid MalignanciesStatus unknownNCT03221400Phase 1/2
- Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionCompletedNCT03202992Phase 1
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Study of Pomalidomide in Anal Cancer PrecursorsStatus unknownNCT03113942Phase 2
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryCompletedNCT02997553Phase 3
- CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating CarcinomasCompletedNCT02981862Not applicable
- Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated RadiotherapyCompletedNCT02949596
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery?TerminatedNCT02885142Not applicable
- New Strategies to Assess Anal Cancer Risk In WomenCompletedNCT02873741
- A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the AnusWithdrawnNCT02857608Phase 2
- Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With MenActive, not recruitingNCT02816879Not applicable
- Shared Decision Making With Anal Cancer Patients on Radiation DoseCompletedNCT02785263Not applicable
- Individual Following in Anal Cancer With PET/CTCompletedNCT02697084